TechnoPhage, SA - From science to innovative biopharmaceuticals
PRESS RELEASE Ontem, dia 15 de janeiro de 2019, foi assinada a constituição da Associação, VectorB2B – Drug Developing – Associação para Investigação em Biotecnologia. O Vector B2B resultou da iniciativa partilhada de sete entidades, o Laboratório Medinfar, S.A., a BEVAG, a Faculdade de Medicina, a Faculdade de Farmácia e a Faculdade de…
Technophage was present at the 3rd edition of the "Innovation Sessions" event held in Brussels on 4 June 2018 at the European Economic and Social Council. This edition of the event was dedicated to the theme "Healthcare Systems and Future Therapies", and was attended by several speakers, Portuguese and international, from all areas…
TechnoPhage amongst the top Portuguese companies with the highest activity of international patenting. Read the article here.
Miguel Garcia, CEO of TechnoPhage, attended MICROBIOTEC'17 to discuss the challenges and opportunities of the biopharmaceutical industry in a round table with representatives of COTEC Portugal, ANI - National Innovation Agency, Amyris Biotechnologies, and AICEP Portugal Global. Click here to know more about the congress.

2019 events

18th Fraunhofer Seminar "Models of Lung Disease"
Hannover, Germany. January 24 - 25, 2019

Phage Futures Congress
Washington DC. January 29-30, 2019

Bacteriophage Therapy Summit
Boston, MA. March 26-27, 2019

29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Amsterdam, Netherlands. April 13-16, 2019